Abstract
Purpose Sepsis, a life-threatening condition from an uncontrolled immune response to infection, is a leading cause of in-hospital mortality. Early detection is crucial, yet traditional diagnostic methods, like SIRS and SOFA, often fail to identify sepsis in non-ICU settings where monitoring is less frequent. Recent machine learning (ML) models offer new possibilities but lack generalizability and suffer from high false alarm rates.
Methods We developed a deep learning (DL) model tailored for non-ICU environments, using MIMIC-IV data with a conformal prediction framework to handle uncertainty. The model was trained on 83,813 patients and validated with the eICU-CRD dataset to test performance across hospital settings.
Results Our model predicted sepsis at 24, 12, and 6 h before onset, achieving AUROCs of 0.96, 0.98, and 0.99, respectively. The conformal approach reduced false positives and improved specificity. External validation confirmed similar performance, with a 57% reduction in false alarms at the 6 h window, supporting practical use in low-monitoring environments.
Conclusions This DL-based model enables accurate, early sepsis prediction with minimal data, addressing key clinical challenges and potentially improving resource allocation in hospital settings by reducing unnecessary ICU admissions and enhancing timely interventions.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study was funded by R35GM150695 (ASB).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The study used ONLY openly available human data that were originally located at https://physionet.org/
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
All data produced in the present study are available upon reasonable request to the authors.
8. Glossary
- Sepsis
- A life-threatening condition arising from the body’s dysregulated immune response to an infection, potentially leading to tissue damage, organ failure, and death.
- Systemic Inflammatory Response Syndrome (SIRS)
- A clinical syndrome characterized by systemic inflammation.
- Sequential Organ Failure Assessment (SOFA)
- A scoring system that assesses the extent of a patient’s organ function or rate of failure.
